Medicare Enrolled
Dr. Charles Woolums, MD
Urology Physician · Portsmouth, OH
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Woolums from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Woolums?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Woolums
Dr. Charles Woolums is an urology physician in Portsmouth, OH, with 21 years of NPI registration. Based on federal Medicare data, Dr. Woolums performed 1,387 Medicare services across 1,122 unique beneficiaries.
Between the years covered by Open Payments, Dr. Woolums received a total of $10,509 from 37 pharmaceutical and/or device companies across 212 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Woolums is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 21 years in practice
▲ Top 37% volume in OH
$10,509 industry payments
Medicare Practice Summary
Medicare Utilization ↗1,387
Medicare services
Top 37% in OH for urology physician
1,122
Unique beneficiaries
$76
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~66 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
449 | $47 | $110 |
| Cystourethroscopy A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract. |
178 | $56 | $803 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
137 | $71 | $166 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
79 | $92 | $282 |
| Cystoscopy with chemical ablation of bladder A procedure where a camera is used to examine the bladder and a chemical agent is applied to destroy abnormal tissue. |
45 | $125 | $410 |
| Ureteral stent insertion via endoscope A flexible tube is inserted into the ureter using an endoscope to keep the passage open and allow urine to flow from the kidney to the bladder. |
41 | $87 | $1,375 |
| Imaging of urinary tract with contrast An imaging test of the urinary tract performed after a contrast agent is injected to enhance visibility of the structures. |
40 | $18 | $75 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
37 | $57 | $177 |
| Endoscopic removal of foreign body, stone, or stent from urethra or bladder A procedure to remove a foreign object, stone, or stent from the urethra or bladder using an endoscope. The endoscope is a thin tube with a camera inserted into the urinary tract to locate and extract the item. |
36 | $114 | $934 |
| Ureteral stone crushing with stent insertion An endoscope is used to break up a stone in the ureter, followed by the placement of a stent to keep the ureter open. |
34 | $312 | $850 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
34 | $61 | $110 |
| Non-needle muscle activity measurement of bladder and bowel openings This procedure measures and records the electrical activity of muscles at the bladder and bowel openings without using needles. |
32 | $13 | $214 |
| Complex urodynamic pressure flow study A test that measures the pressure of urine flow in the bladder during voiding to evaluate how well the bladder and urethra are functioning. |
30 | $74 | $176 |
| Hospital follow-up visit, low complexity Follow-up hospital visit for an established patient with straightforward or low-level medical decision making. The visit requires at least 25 minutes of time spent on the day of service. |
30 | $38 | $109 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
29 | $27 | $75 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
29 | $129 | $295 |
| Laser vaporization of prostate A procedure that uses a laser to remove excess prostate tissue through an endoscope. The process includes controlling any bleeding that occurs during the treatment. |
25 | $529 | $3,500 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
25 | $96 | $210 |
| Bladder irrigation and/or instillation This procedure involves flushing the bladder with fluid to clear it or introducing medication directly into the bladder. |
19 | $23 | $250 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
14 | $92 | $150 |
| Abdominal device insertion with pressure and urine flow study A procedure involving the placement of a device into the abdomen, accompanied by a study to measure pressure and urine flow rate. |
11 | $31 | $150 |
| Endoscopic destruction of bladder, urethra, or gland tissue A procedure that uses an endoscope to destroy tissue in the bladder, urethra, or surrounding glands. |
11 | $106 | $1,975 |
| Prostate gland biopsy A procedure to remove small samples of tissue from the prostate gland for laboratory examination. |
11 | $99 | $615 |
| Ultrasound guidance for needle placement Use of ultrasound imaging to guide the precise placement of a needle during a medical procedure. |
11 | $24 | $200 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
11.2% high complexity
4.5% medium
84.3% routine
Industry Payment Transparency
Open Payments through 2024 ↗$10,509
Total received (2018-2024)
Avg $1,501/year across 7 years
Top 16% in OH for urology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
37
Companies
212
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$10,083 (96.0%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$425 (4.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$406
2023
$330
2022
$348
2021
$1,874
2020
$702
2019
$2,128
2018
$4,721
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
PROCEPT BioRobotics Corporation
$193
Axonics, Inc.
$180
Boston Scientific Corporation
$17
Medtronic, Inc.
$16
Top 3 companies account for 96.1% of 2024 payments
All-time payments by company (2018-2024) ›
NeoTract Inc.
$4,485
Medtronic USA, Inc.
$1,303
Teleflex LLC
$1,058
PROCEPT BioRobotics Corporation
$631
Astellas Pharma US Inc
$547
Endo Pharmaceuticals Inc.
$409
Axonics, Inc.
$265
Olympus America Inc.
$251
Janssen Pharmaceuticals, Inc
$200
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$191
Antares Pharma, Inc.
$155
Medtronic, Inc.
$121
PFIZER INC.
$118
Axonics Modulation Technologies, Inc.
$116
Janssen Biotech, Inc.
$92
TherapeuticsMD, Inc.
$81
Janssen Scientific Affairs, LLC
$57
Avanir Pharmaceuticals, Inc.
$56
Amgen Inc.
$52
Travere Therapeutics, Inc.
$47
Merck Sharp & Dohme LLC
$44
Coloplast Corp
$24
Daiichi Sankyo Inc.
$19
Boston Scientific Corporation
$17
Myovant Sciences Inc.
$17
Mylan Specialty L.P.
$16
Retrophin, Inc.
$16
Shire North American Group Inc
$14
COLOPLAST CORP
$14
Bayer HealthCare Pharmaceuticals Inc.
$13
Novo Nordisk Inc
$13
Vifor Pharma, Inc.
$12
Allergan Inc.
$12
Biohaven Pharmaceuticals, Inc.
$12
Amarin Pharma Inc.
$11
Takeda Pharmaceuticals U.S.A., Inc.
$11
AbbVie, Inc.
$11
Top 3 companies account for 65.1% of all-time payments
Associated products mentioned in payments ›
(815) Thiola · AQUABEAM ROBOTIC SYSTEM · AQUABEAM SYSTEM · AVEED · Aimovig · AquaBeam Robotic System · Axonics · Axonics r-SNM System · BOTOX THERAPEUTIC · EVENITY · Erleada · IMVEXXY · INJECTAFER · INTERSTIM · INVOKAMET · INVOKANA · ImaJin · KEYTRUDA · Kerendia · MYRBETRIQ · NOCDURNA · NUEDEXTA · NURTEC ODT · ORGOVYX · Ozempic · Soltive · Synthroid · TITAN · TLANDO · TOVIAZ · TRINTELLIX · Thiola · Tria Firm · UROLIFT · UroLift · UroLift System · VYVANSE · Vascepa · Veltassa · XARELTO · XIAFLEX · XIFAXAN · XTANDI · XYOSTED · Yupelri · iTIND System
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (96%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Urology physicians within 10 mi
2
Per 100K population
2.7
County median income
$49,571
Nearest hospital
SOUTHERN OHIO MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Woolums is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement in the top 16% of OH peers, with 21 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Woolums experienced with office visit, established patient (20-29 min)?
Based on Medicare claims data, Dr. Woolums performed 449 office visit, established patient (20-29 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Woolums receive payments from pharmaceutical companies?
Yes. Dr. Woolums received a total of $10,509 from 37 companies across 212 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Woolums's costs compare to other urology physicians in Portsmouth?
Dr. Woolums's average Medicare payment per service is $76. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Woolums) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Urology Physicians in Portsmouth
Browse urology physicians in Portsmouth ranked by procedure volume and transparency data.
Highest volume
Top Urology Physicians in OH
Urology physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Urology Physicians in OH
Which OH urology physicians receive the most from drug and device companies.
By company
NeoTract Inc. Payments to Doctors
See all physicians who received payments from NeoTract Inc.
By company
Medtronic USA, Inc. Payments to Doctors
See all physicians who received payments from Medtronic USA, Inc.
By company
Teleflex LLC Payments to Doctors
See all physicians who received payments from Teleflex LLC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology